Eikon Therapeutics Email Format

Biotechnology ResearchCalifornia, United States201-500 Employees

Eikon Therapeutics is a biotechnology company advancing late-stage clinical development of novel medicines to address unmet medical needs. In oncology, its programs focus on modulating immune responses and exploiting synthetic lethality to improve cancer therapy. The company’s discovery efforts aim to identify new targets by applying single-molecule imaging to cancer and neurological diseases. 

By integrating insights from large imaging datasets with machine learning, Eikon seeks to accelerate progression of its programs toward clinical impact. Based in Millbrae, California, the organization employs hundreds of people, and in May 2026 announced the publication of full-text abstracts from its lead programs for presentation at the ASCO Annual Meeting.

Sign up for free to view info

Company overview Employee directory